Garrabou G - Search Results

1

Fibroblast phenylalanine concentration as a surrogate biomarker of cellular number.

Oliva C, Arias A, Ruiz M, Pujol A, Garrabou G, Canto-Santos J, Urreizti R, Castilla-Vallmanya L, Rodriguez-Gonzalez H, Jou C, Casado M, Ormazabal A, Artuch R. Oliva C, et al. Among authors: garrabou g. J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Jul 15;1226:123787. doi: 10.1016/j.jchromb.2023.123787. Epub 2023 Jun 10. J Chromatogr B Analyt Technol Biomed Life Sci. 2023. PMID: 37327517

2

[Treatment of symptomatic hyperlactatemia and lactic acidosis in HIV+ patients under nucleoside reverse transcriptase inhibitors].

Pedrol E, Ribell M, Deig E, Villà Mdel C, Miró O, Garrabou G, Soler A. Pedrol E, et al. Among authors: garrabou g. Med Clin (Barc). 2005 Jul 9;125(6):201-4. doi: 10.1157/13077376. Med Clin (Barc). 2005. PMID: 16022831 Spanish.

3

Mitochondrial DNA (mtDNA) variants in the European haplogroups HV, JT, and U do not have a major role in schizophrenia.

Torrell H, Salas A, Abasolo N, Morén C, Garrabou G, Valero J, Alonso Y, Vilella E, Costas J, Martorell L. Torrell H, et al. Among authors: garrabou g. Am J Med Genet B Neuropsychiatr Genet. 2014 Oct;165B(7):607-17. doi: 10.1002/ajmg.b.32264. Epub 2014 Aug 17. Am J Med Genet B Neuropsychiatr Genet. 2014. PMID: 25132006

4

Short communication metabolic and mitochondrial effects of switching antiretroviral-experienced patients to enfuvirtide, tenofovir and saquinavir/ritonavir.

Miró O, Garrabou G, López S, Deig E, Vidal I, Infante AB, Cardellach F, Casademont J, Pedrol E. Miró O, et al. Among authors: garrabou g. Antivir Ther. 2006;11(5):625-30. Antivir Ther. 2006. PMID: 16964831

5

Partial immunological and mitochondrial recovery after reducing didanosine doses in patients on didanosine and tenofovir-based regimens.

Negredo E, Garrabou G, Puig J, Lòpez S, Morén C, Bellido R, Ayen R, Cardellach F, Miró O, Clotet B. Negredo E, et al. Among authors: garrabou g. Antivir Ther. 2008;13(2):231-40. Antivir Ther. 2008. PMID: 18505174

6

The impact of reducing stavudine dose versus switching to tenofovir on plasma lipids, body composition and mitochondrial function in HIV-infected patients.

Milinkovic A, Martinez E, López S, de Lazzari E, Miró O, Vidal S, Blanco JL, Garrabou G, Laguno M, Arnaiz JA, Leon A, Larrousse M, Lonca M, Mallolas J, Gatell JM. Milinkovic A, et al. Among authors: garrabou g. Antivir Ther. 2007;12(3):407-15. Antivir Ther. 2007. PMID: 17591031 Clinical Trial.

7

Mild improvement in mitochondrial function after a 3-year antiretroviral treatment interruption despite persistent impairment of mitochondrial DNA content.

Negredo E, Romeu J, Rodríguez-Santiago B, Miró O, Garrabou G, Puig J, Pérez-Alvarez N, Moren C, Ruiz L, Bellido R, Miranda C, Clotet B. Negredo E, et al. Among authors: garrabou g. Curr HIV Res. 2010 Jul;8(5):379-85. doi: 10.2174/157016210791330374. Curr HIV Res. 2010. PMID: 20426759

8

Noninvasive diagnosis of mitochondrial dysfunction in HAART-related hyperlactatemia.

Garrabou G, Sanjurjo E, Miró O, Martínez E, Infante AB, López S, Cardellach F, Gatell JM, Casademont J. Garrabou G, et al. Clin Infect Dis. 2006 Feb 15;42(4):584-5. doi: 10.1086/500014. Clin Infect Dis. 2006. PMID: 16421815 No abstract available.

9

Mitochondrial effects of a 24-week course of pegylated-interferon plus ribavirin in asymptomatic HCV/HIV co-infected patients on long-term treatment with didanosine, stavudine or both.

Ballesteros AL, Miró O, López S, Fuster D, Videla S, Martínez E, Garrabou G, Salas A, Côté H, Tor J, Rey-Joly C, Planas R, Clotet B, Tural C. Ballesteros AL, et al. Among authors: garrabou g. Antivir Ther. 2004 Dec;9(6):969-77. Antivir Ther. 2004. PMID: 15651755 Clinical Trial.

10

Improvement of mitochondrial toxicity in patients receiving a nucleoside reverse-transcriptase inhibitor-sparing strategy: results from the Multicenter Study with Nevirapine and Kaletra (MULTINEKA).

Negredo E, Miró O, Rodríguez-Santiago B, Garrabou G, Estany C, Masabeu A, Force L, Barrufet P, Cucurull J, Domingo P, Alonso-Villaverde C, Bonjoch A, Morén C, Pérez-Alvarez N, Clotet B; MULTINEKA Study Group. Negredo E, et al. Among authors: garrabou g. Clin Infect Dis. 2009 Sep 15;49(6):892-900. doi: 10.1086/605440. Clin Infect Dis. 2009. PMID: 19663689 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

121 results

Search Page

Filters